Skip to main content
O-024

O-024: Entrectinib in NTRKFusion-Positive Gastrointestinal Cancers: Integrated Analysis of Patients Enrolled in Three Trials (ALKA-372-001, STARTRK-1 and STARTRK-2)

This browser does not support PDFs. Please download the PDF to view it: Download PDF.